This autonomous activation occurs in BCC and medulloblastoma [11,59] and results from loss-of-function mutations in PTCH or SUFU, or gain-of-function mutations in SMO [56,62,65,66]. This evidence concerns the gene SMO and skin basal cell carcinoma.